NCT01783132View on ClinicalTrials.gov

Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home

NATerminatedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

December 1, 2012

Primary Completion Date

April 1, 2014

Study Completion Date

April 28, 2014

Conditions
Asthma
Interventions
DEVICE

NIOX MINO

Active group (Budesonide) will be measuring exhaled NO at least 3 times/week at home to control their Asthma treatment via a algorithm schedule. The control group (Standard of care) will be measuring exhaled NO 4 times/year at study site.

Trial Locations (1)

751 85

Lungkliniken, Universitetssjukhuset i Uppsala, Uppsala

Sponsors

Collaborators (1)

Aerocrine AB
All Listed Sponsors
collaborator

Aerocrine AB

INDUSTRY

lead

Orion Corporation, Orion Pharma

INDUSTRY